Status: Enrolling
Investigator: Raj Satkunasivam
Study Coordinator: Cinthya Yesenia Obando Perez
Phone: 346.238.6123
This randomized phase III trial studies Tokyo-172 strain bacillus Calmette-Guerin (BCG) solution with or without a vaccination using Tokyo-172 strain BCG to see how well it works compared with TICE BCG solution in treating patients with bladder ... Read more >
Status: Enrolling
Investigator: Raj Satkunasivam
Study Coordinator:
Phone:
This is a Phase 3, Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to evaluate the efficacy of Infigratinib in adult patients with invasive urothelial carcinoma with susceptible FGFR3 genetic alterations (mutations, and gene fusi ... Read more >
Status: Open Not Enrolling
Investigator: Jorge Darcourt
Study Coordinator: Syed Muhammad Saad
Phone: 281.276.5263
This is a randomized, open-label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877) compared to chemotherapy in patients with FGFRpositive locally advanced or metastatic urothelial carcinoma who have re ... Read more >
Status: Enrolling
Investigator: Raj Satkunasivam
Study Coordinator: Cinthya Yesenia Obando Perez
Phone: 346.238.6123
Primary Purpose: Treatment ... Read more >